Does the new angiotensin converting enzyme inhibitor cilazapril prevent restenosis after percutaneous transluminal coronary angioplasty? Results of the MERCATOR study: a multicenter, randomized, double-blind placebo-controlled trial. Multicenter Euro (Q61651563)
scientific article published on 01 July 1992
Language:
(P31) (Q13442814)
(P304) 100-110
(P407) (Q1860)
(P433) 1
(P478) 86
(P577) Wednesday, July 1, 1992
(P921) (Q269829)
(Q6934595)
(Q539795)
(P1433) (Q578091)
(P1476) "Does the new angiotensin converting enzyme inhibitor cilazapril prevent restenosis after percutaneous transluminal coronary angioplasty? Results of the MERCATOR study: a multicenter, randomized, double-blind placebo-controlled trial. Multicenter European Research Trial with Cilazapril after Angioplasty to Prevent Transluminal Coronary Obstruction and Restenosis (MERCATOR) Study Group" (language: en)
other details
description scientific article published on 01 July 1992

External Links